As returns on market increase, BioCryst returns are expected to increase less than the market. However during bear market, the loss on holding BioCryst will be expected to be smaller as well.
William Sheridan Senior Vice President Chief Medical Officer, Ph.D
BioCryst Price and Market Media
The median price of BioCryst for the period between Sun, May 19, 2013 and Tue, Jun 18, 2013 is 1.7 with a coefficient of variation of 2.43. The daily time series for the period is distributed with a sample standard deviation of 0.04, arithmetic mean of 1.68, and mean deviation of 0.03. The Stock received substential amount of media coverage during this period.
BioCryst Pharmaceuticals Inc [BCRX] is traded on NASDAQ in USA. It is located in BioCryst Pharmaceuticals, Inc.Durham, NC and employs 40 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 93.01 M. BioCryst Pharmaceuticals Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 53.15 M outstanding shares of which 5.06 M shares are currently shorted by private and institutional investors with about 2.1 trading days to cover.
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
0.78% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
